Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Innoveren Scientific, Inc. (IVRN) had Debt to Equity Ratio of -0.41 for the most recently reported fiscal year, ending 2022-12-31.
| Income Statement Financials | |
$0.45M |
|
$-10.30M |
|
$0.12M |
|
$0.34M |
|
$5.56M |
|
$-5.11M |
|
$-5.19M |
|
$-10.30M |
|
$-10.30M |
|
$-10.30M |
|
$-10.30M |
|
$-10.30M |
|
$-10.30M |
|
$-5.11M |
|
$-5.59M |
|
0.29M |
|
0.29M |
|
$-35.06 |
|
$-35.06 |
|
| Balance Sheet Financials | |
$0.08M |
|
$0.02M |
|
$0.05M |
|
$0.14M |
|
$7.48M |
|
-- |
|
$2.02M |
|
$9.49M |
|
$-9.80M |
|
$-9.36M |
|
$-9.36M |
|
0.62M |
|
| Cash Flow Statement Financials | |
$-1.91M |
|
$0.00M |
|
$1.82M |
|
$0.10M |
|
-- |
|
$-0.10M |
|
$0.59M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.01 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-0.41 |
74.07% |
|
-1125.96% |
|
-1125.96% |
|
-1232.89% |
|
-2271.33% |
|
-2271.33% |
|
$-1.91M |
|
-- |
|
-- |
|
-- |
|
3.30 |
|
-- |
|
15.39 |
|
23.72 |
|
105.14% |
|
110.07% |
|
-7498.40% |
|
110.07% |
|
$-15.12 |
|
$-6.51 |
|
$-6.51 |
|